Significant Ownership of Inscobee Inc.

Signature - Title: /s/ You In Soo - You In Soo, Chief Executive Officer
Location: Seoul, Korea, Republic of
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Inscobee Inc..

Notify me when Inscobee Inc. files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
APUS	Apimeds Pharmaceuticals US, Inc.	Common Stock	34%	$8,460,571	-$139,336	4,316,618	-1.6%	Apimeds Inc.	01 Dec 2025

Schedules 13D/G Reported by Inscobee Inc.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.